BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 103 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,825,000 | -65.8% | 12,070 | -67.0% | 0.00% | -60.0% |
Q2 2022 | $5,337,000 | +15.8% | 36,629 | -5.8% | 0.01% | +25.0% |
Q1 2022 | $4,608,000 | -8.9% | 38,867 | +5.9% | 0.00% | 0.0% |
Q4 2021 | $5,058,000 | +84.8% | 36,700 | +86.2% | 0.00% | +100.0% |
Q3 2021 | $2,737,000 | +42.3% | 19,705 | -0.6% | 0.00% | 0.0% |
Q2 2021 | $1,924,000 | +50.9% | 19,817 | +6.2% | 0.00% | +100.0% |
Q1 2021 | $1,275,000 | +26.6% | 18,659 | +58.8% | 0.00% | 0.0% |
Q4 2020 | $1,007,000 | +27.8% | 11,752 | -3.0% | 0.00% | 0.0% |
Q3 2020 | $788,000 | -4.0% | 12,116 | +7.9% | 0.00% | 0.0% |
Q2 2020 | $821,000 | +113.2% | 11,232 | -0.7% | 0.00% | 0.0% |
Q1 2020 | $385,000 | -24.7% | 11,309 | +20.4% | 0.00% | 0.0% |
Q4 2019 | $511,000 | -10.4% | 9,391 | -31.3% | 0.00% | 0.0% |
Q3 2019 | $570,000 | -6.1% | 13,664 | -1.4% | 0.00% | 0.0% |
Q2 2019 | $607,000 | -31.6% | 13,863 | -19.7% | 0.00% | 0.0% |
Q1 2019 | $888,000 | +40.3% | 17,259 | +0.9% | 0.00% | 0.0% |
Q4 2018 | $633,000 | -2.8% | 17,111 | -1.4% | 0.00% | 0.0% |
Q3 2018 | $651,000 | -6.2% | 17,350 | -1.3% | 0.00% | 0.0% |
Q2 2018 | $694,000 | +53.2% | 17,572 | -0.2% | 0.00% | 0.0% |
Q1 2018 | $453,000 | +1.8% | 17,604 | +6.6% | 0.00% | 0.0% |
Q4 2017 | $445,000 | -24.4% | 16,509 | +4.8% | 0.00% | 0.0% |
Q3 2017 | $589,000 | +49.9% | 15,751 | +0.3% | 0.00% | 0.0% |
Q2 2017 | $393,000 | – | 15,710 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |